News

BioMed SA eyes new road map to greater economic wins

BioMed SA President Ann Stevens (Photo by Lyndsey Johnson) By W. Scott Bailey, San Antonio Business ...

Military champion has Prytime Medical ready for prime time

Prytime Medical Devices Inc. CEO David Spencer said his company is poised to take its flagship technology ...

Industry Publications

The Mission

The Mission is published by the University of Texas Health Science Center.

UTSA Discovery

UTSA Discovery is published annually for the Office of the Vice President for Research by the Office ...

News
Texas Biomed files patent for novel HIV vaccine
November 19, 2012

By W. Scott Bailey, San Antonio Business Journal

The Texas Biomedical Research Institute (Texas Biomed) has applied for a patent for a genetically-engineered vaccine strategy to prevent HIV infection.

The novel vaccine targets the outer layers of body structures that first come into contact with the virus.

The vaccine is designed so that it can be administered in a single dose and last the patient a lifetime. Texas Biomed officials say it could be adapted for use against other infections, as well.

"The development of an effective AIDS vaccine that restricts viral replication at the mucosal level of entry may be our best hope for controlling the HIV pandemic," says Marie-Claire Gauduin, Ph.D., who works in Texas Biomed's Department of Virology and Immunology and is a co-inventor on the patent with Philippe Blancou, Ph.D., a visiting scientist from the University of Nice-Sophia Antipolis in France.

"Only life-long stimulation of the immune system by the vaccine will be sufficient to achieve long-term protection," she adds.

One of the main reasons for the failure of HIV vaccines thus far is their inability to deliver antibody-producing cells for prolonged periods of time, thus only achieving weak and transient protection at best.

San Antonio-based Texas Biomed is one of the world's leading independent biomedical research institutions.

 

Stay informed. Subscribe to BioMed SA news alerts.